Article Text

Download PDFPDF
IDDF2024-ABS-0278 Integrative multi-omics reveal associations between gut microbiome and immune response against COVID-19 vaccine in the elderly
  1. Rong Quan1,
  2. Jingxiang Zhang1,
  3. Jiahua Liu1,
  4. Xiaoshuang Xu1,
  5. Jiale Xie1,
  6. Guobin Chen2,
  7. Evandro Fei Fang3,
  8. Wei Qi1,
  9. Zhijie Feng1
  1. 1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Hebei, China
  2. 2Institute of Geriatric Immunology, Department of Microbiology and Immunology, School of Medicine, Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Key Laboratory of Viral Pathogenesis and Infection Prevention and Control, Jinan University, Guangzhou, China
  3. 3Department of Clinical Molecular Biology, Akershus University Hospital, University of Oslo, Oslo, Norway. The Norwegian Centre on Healthy Ageing, Oslo, Norway

Abstract

Background Several recent studies suggested that gut microbiota are crucial in modulating immune responses to COVID-19 vaccination. However, the majority of these studies have focused on younger populations, and the effects of gut microbiota on COVID-19 vaccine-induced immune responses in the elderly remain elusive.

Methods We recruited 25 subjects (aged 64-86 years) who required the fourth dose of a recombinant COVID-19 vaccine (ZF2001) for multi-omics analysis, including metagenomics, metabolomics, single-cell RNA sequencing (scRNA-seq), single-cell T-cell receptor/B-cell receptor sequencing (scTCR/BCR-seq). And mendelian randomisation (MR) was applied to analyse the causal relationship between gut microbiota and plasma phosphatidylcholines (PCs) (IDDF2024-ABS-0278 Figure 1. Research design and data collection diagram).

Results Elevations in the levels of the Bifidobacterium genus, specifically B. dentium and B. pseudocatenulatum, were detected in the fecal samples of the high-response group. Notably, these Bifidobacterium species revealed a correlation with the ratio of neutralizing antibodies measured on Day 28 compared to Day 0. Furthermore, untargeted metabolomics analysis revealed that the upregulated differential fecal metabolites in the high-response group predominantly consisted of PCs, exhibiting an approximately tenfold increase in abundance. Moreover, the results of MR revealed that Bifidobacterium had an effect on PCs, well confirming the association between Bifidobacterium and PCs. Flow cytometric analysis revealed that the CD4/CD8 ratio is upregulated in the low-response group, indicating an elevated level of immunosenescence. scRNA-seq data further validated the immunosenescent status of the low-response group. scRNA-seq showed that the percentages of Naive B cells were lower (P<0.05) and Non-switched memory B cells were higher in the low response group (P<0.05). Meanwhile, single-cell immune repertoire analysis showed that the total clone of TCRβ-CDR3 against 6 viruses increased in the high response group (P<0.05).

Abstract IDDF2024-ABS-0278 Figure 1

Research design and data collection diagram

Conclusions Multi-omics analyses showed lower immunosenescence in the high response group, accompanied by increased intestinal B.dentium and B.pseudocatenulatum as well as PCs. The potential utility of Bifidobacterium and phosphatidylcholines (PCs) as functional foods to enhance COVID-19 vaccination efficacy in immunosenescent elders requires further investigation.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.